NCT05355298
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05355298
Title AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Amplia Therapeutics Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
GenesisCare St Leonards New South Wales 2065 Australia Details
Calvary Mater Newcastle Waratah New South Wales 2298 Australia Details
Westmead Hospital Westmead New South Wales 2145 Australia Details
Gallipolli Medical Research Foundation Greenslopes Queensland 4120 Australia Details
Epworth Healthcare Box Hill Victoria 3128 Australia Details
Monash Health Clayton Victoria 3168 Australia Details
Epworth Healthcare Richmond Victoria 3121 Australia Details
Western Health St Albans Victoria 3021 Australia Details
National Cancer Centre Gyeonggi-do 10408 South Korea Details
Seoul National University Bundang Hospital Gyeonggi-do 13620 South Korea Details
Severence Hospital Seoul 03722 South Korea Details
Seoul National University Hospital Seoul 3080 South Korea Details
Samsung Medical Centre Seoul 6351 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field